Drug intelligence / Profile preview

alpha-Fluoro-carboxymethyldethia coenzyme A complex

Development stage
Unknown
Lead developer
Stanford University
Modality
Small Molecules
01

Overview

alpha-Fluoro-carboxymethyldethia coenzyme A complex is a synthetic analog of acetyl-coenzyme A in which the sulfur atom is replaced by a methylene group and an additional fluorine atom is introduced at the alpha position. It acts as a potent inhibitor of citrate synthase, the enzyme that catalyzes the first step in the citric acid (Krebs) cycle. The compound forms stable ternary complexes with oxaloacetate and citrate synthase, mimicking transition state or intermediate structures during catalysis. Structural studies have shown that this inhibitor binds to citrate synthase with high affinity through unusually short hydrogen bonds to Asp 375 in the active site. The introduction of an alpha-fluorine increases hydrogen bond strength due to pKa matching between donor and acceptor groups[5][8]. This compound has been used primarily as a biochemical tool for mechanistic enzymology studies rather than as a therapeutic agent.

Other names
FCXalpha-fluoro acid analog of acetyl-CoA(2S)-4-[3-[[(2R)-4-(3-Phosphonoxy-3-oxopropylamino)-2,2-dimethyl-3-hydroxybutanoyl]amino]propylamino]-4-oxobutanoic acid derivative
02

Targets

CS (Chondroitin sulfate)

Beyond the preview

Go deeper on alpha-Fluoro-carboxymethyldethia coenzyme A complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-Fluoro-carboxymethyldethia coenzyme A complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call